Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02085941 · ClinicalTrials.gov registry record · NA
Image-guided Cryoablation of Head, Neck and Spine Tumors
A NA study of Head and Neck Neoplasms and Malignant Neoplasm of Vertebral Column, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT02085941: Completed NA study of Head and Neck Neoplasms and Malignant Neoplasm of Vertebral Column, sponsored by Dana-Farber Cancer Institute.
NCT02085941 is a NA study of Head and Neck Neoplasms and Malignant Neoplasm of Vertebral Column that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 30 participants, below the 264-participant average among 23 other Head and Neck Neoplasms trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02085941, a NA study of Head and Neck Neoplasms and Malignant Neoplasm of Vertebral Column, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research study is evaluating a procedure called cryoablation (the removal of diseased tissue using extreme freezing temperatures) as a possible treatment for head, neck and spine tumors.
Primary Outcome
Assess the number of adverse events from time of procedure to one month post-procedure.
Conditions Studied
Interventions
- DEVICE Cryoablation
- DEVICE Biopsy
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-02 |
| Est. Completion | 2021-07 |
| Phase | NA |
What the finished NCT02085941 record still lists
NCT02085941 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 264-participant average among 23 other Head and Neck Neoplasms trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Head and Neck Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Cryoablation is the first listed.
NCT02085941 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02085941 about?
NCT02085941 is a clinical study titled "Image-guided Cryoablation of Head, Neck and Spine Tumors". This research study is evaluating a procedure called cryoablation (the removal of diseased tissue using extreme freezing temperatures) as a possible treatment for head, neck and spine tumors.
What is the current status of trial NCT02085941?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-02. Estimated completion is 2021-07.
What conditions does trial NCT02085941 study?
This clinical trial studies the following conditions: Head and Neck Neoplasms, Malignant Neoplasm of Vertebral Column.
What interventions are being tested in trial NCT02085941?
The interventions under investigation include: Cryoablation (DEVICE), Biopsy (DEVICE).
Who is sponsoring clinical trial NCT02085941?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02085941 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02085941's enrollment target sits among peer trials
30 17th of 23 higher than 5 of 23 other Head and Neck Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Head and Neck Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMST in Patients Undergoing CRT for HNCA
RECRUITING · NA
-
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
RECRUITING · NA
-
Head and Neck Cancer Study Project in the Geriatric Population
RECRUITING · Phase 3
-
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
RECRUITING
-
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
RECRUITING · Phase 2
-
Molecular and Genomic Profiling of Head and Neck Tumors
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia